Para-aminobenzoic Acid (paba) + Evinacumab-Dgnb
Evinacumab-Dgnb brand name: Evkeeza.
We found no known interaction between Para-aminobenzoic Acid (paba) and Evinacumab-Dgnb in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.
Para-aminobenzoic Acid (paba) and Evinacumab-Dgnb
We checked these two against our interaction database. Here is what we found.
No Known Interaction Found
We did not find a documented interaction between Evinacumab-Dgnb and Para-aminobenzoic Acid (paba) in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.
If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.
Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.
Para-aminobenzoic Acid (paba) safety at a glance
Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center) — the full detail is in the Special populations card below. Safety guidance is general; always confirm with your pharmacist or doctor for your situation.
Para-aminobenzoic Acid (paba) Does Interact With Other Medications
Para-aminobenzoic Acid (paba) has 17 major, known drug interactions in our database — Evinacumab-Dgnb isn’t one of them. If you take anything else, check it against the full list below.
Check Another of Your Medications Against Para-aminobenzoic Acid (paba)
We haven’t checked that one against Para-aminobenzoic Acid (paba) yet — ask our pharmacists directly.
Covers the 2,830 medications we’ve checked against Para-aminobenzoic Acid (paba). Pick one to open its full report.
Para-aminobenzoic Acid (paba) in Pregnancy & Breastfeeding
When used topically and appropriately. There is insufficient reliable information available about the safety of the oral use of PABA during pregnancy and breast-feeding; avoid using.
DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.© 2026 Therapeutic Research Center
Where Para-aminobenzoic Acid (paba) and Evinacumab-Dgnb Sit Against Everything Else
Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.
#935 of 1,452 supplements looked up here in the last 7 days
#2,471 of 2,830 medications looked up here in the last 7 days
Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.
Where does our data come from?
- Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
- Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Para-aminobenzoic Acid (paba) reference on this page ↓
- Freshness: we automatically re-check this combination every week — this pair was last verified September 27, 2026. The Para-aminobenzoic Acid (paba) and Evinacumab-Dgnb records this page draws on were last updated July 10, 2026.
- What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
About Para-aminobenzoic Acid (paba)
What is Para-aminobenzoic Acid (paba)?
- Skin conditions like vitiligo
- Scleroderma and skin tightening conditions
- Graying hair
- Sunscreen ingredient (older topical products)
- General supplement and 'B-complex' support
PABA (para-aminobenzoic acid) is a chemical sometimes taken as a supplement or used in older sunscreens. Evidence supporting its oral use for skin conditions, hair color, and other claims is limited and outdated, and high doses can cause side effects. Talk with your pharmacist or doctor before using it.
Not a plant; PABA is a chemical compound (an amino acid-like substance) · Tablets, capsules, and topical creams or lotions
An interaction check asks whether these two react with each other — it does not ask whether Para-aminobenzoic Acid (paba) is a good idea for someone in your situation. Here is what our Para-aminobenzoic Acid (paba) record says about it on its own.
Para-aminobenzoic Acid (paba): dosing
There is no well-established standard dose of PABA for any condition, and high doses have been associated with toxicity. Some older studies used relatively large amounts under medical supervision, but these are not appropriate for routine self-treatment.If you choose to use a PABA product, follow the directions on the label and do not exceed the recommended amount.
From our Para-aminobenzoic Acid (paba) monograph — the full record covers uses, side effects and every documented interaction.
About Evinacumab-dgnb Injection
What Is Evinacumab-dgnb Injection Used For?
Brand name: Evkeeza
-
Evinacumab-dgnb is used in combination with other treatments to reduce the amount low-density lipoprotein (LDL) cholesterol ('bad cholesterol') and other fatty substances in the blood in adults and children 12 years of age or older that have homozygous familial hypercholesterolemia (HoFH; an inherited condition in which cholesterol cannot be removed from the body normally). Evinacumab-dgnb is in a class of medications called angiopoietin-like protein 3 (ANGPTL3) inhibitor monoclonal antibodies. It works by decreasing the production of LDL cholesterol and increasing the breakdown of LDL cholesterol and other fatty substances in the body.
-
Accumulation of cholesterol and fats along the walls of your arteries (a process known as atherosclerosis) decreases blood flow and, therefore, the oxygen supply to your heart, brain, and other parts of your body. Lowering your blood level of cholesterol and fats may help prevent heart disease, angina (chest pain), strokes, and heart attacks.
Other Drugs & Para-aminobenzoic Acid (paba)
Browse every other medication we’ve checked against Para-aminobenzoic Acid (paba) — both the ones with a known interaction and the ones without. Select any drug for the full detail.
No drugs match “”.
17 interactions
- Dapsone ›
- Retapamulin ›
- Doripenem ›
- Sulfadiazine ›
- Sulfamethoxazole ›
- Sulfisoxazole ›
- Tigecycline ›
- Sulfamethoxazole, Trimethoprim ›
- Sulfadiazine, Sulfamerazine, Sulfamethazine ›
- Benazepril, Hydrochlorothiazide ›
- Enalapril Maleate, Hydrochlorothiazide ›
- Erythromycin Ethylsuccinate, Sulfisoxazole ›
- Erythromycin, Sulfisoxazole ›
- Fosinopril, Hydrochlorothiazide ›
- Hydrochlorothiazide, Moexipril ›
- Phenazopyridine, Sulfisoxazole ›
- Sulfadiazine, Trimethoprim ›
No interaction 2,812 drugs checked — show the list
We also checked Para-aminobenzoic Acid (paba) against these medications and found no known interaction in our sources. Open any page to confirm.
- Apixaban ›
- Levothyroxine ›
- Amlodipine ›
- Methylphenidate ›
- Warfarin ›
- Abemaciclib ›
- Ivermectin ›
- Testosterone ›
- Sertraline ›
- Acetaminophen ›
- Losartan Potassium ›
- Aspirin ›
- Rosuvastatin ›
- Metoprolol ›
- Escitalopram ›
- Clopidogrel ›
- Rivaroxaban ›
- Atorvastatin ›
- Isotretinoin ›
- Tirzepatide ›
- Warfarin Sodium ›
- Ibuprofen ›
- Methamphetamine ›
- Amlodipine Besylate ›
- Docusate ›
- Sumatriptan ›
- Valacyclovir ›
- Tadalafil ›
- Hydroxyurea ›
- Prednisone ›
- Metformin ›
- Semaglutide ›
- Lisdexamfetamine ›
- Amitriptyline ›
- Propranolol ›
- Amphetamine ›
- Amoxicillin ›
- Methotrexate ›
- Lisinopril ›
- Levothyroxine, Liothyronine ›
- Bupropion ›
- Fluoxetine ›
- Bendamustine ›
- Azithromycin ›
- Pregabalin ›
- Doxycycline ›
- Dextroamphetamine ›
- Lamotrigine ›
- Gabapentin ›
- Acyclovir ›
- Naproxen ›
- Quetiapine ›
- Clonazepam ›
- Buspirone ›
- Acetaminophen, Aspirin, Caffeine ›
- Omeprazole ›
- Duloxetine ›
- Letrozole ›
- Citalopram ›
- Acetaminophen, Codeine ›
Showing the 60 most looked-up of 2,812 medications checked with no known interaction — see the full Para-aminobenzoic Acid (paba) list.
Para-aminobenzoic Acid (paba) References
The 11 references that drive our Para-aminobenzoic Acid (paba) monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.
- United States Pharmacopeial Convention, Inc., ed. Drug Information for the Health Care Professional. 19th ed. Englewood, CO: Micromedex Inc., 1999.
- Facts and Comparisons staff. Drug Facts and Comparisons. St Louis: Wolters Kluwer Company (updated monthly).
- Covington TR, et al. Handbook of Nonprescription Drugs. 11th ed. Washington, DC: American Pharmaceutical Association, 1996.
- Worobec S, LaChine A. Dangers of orally administered para-aminobenzoic acid. JAMA 1984;251:2348. DOI
- Zarafonetis CJ, Dabich L, DeVol EB, et al. Potassium para-aminobenzoate and liver function test findings. J Am Acad Dermatol 1986;15:144-9. PubMed
- Clegg DO, Reading JC, Mayes MD, et al. Comparison of aminobenzoate potassium and placebo in the treatment of scleroderma. J Rheumatol 1994;21:105-10.
- Ludwig G. Evaluation of conservative therapeutic approaches to Peyronie's disease (fibrotic induration of the penis). Urol Int 1991;47:236-9. PubMed
- Kantor GR, Ratz JL. Liver toxicity from potassium para-aminobenzoate. J Am Acad Dermatol 1985;13:671-2. PubMed
- Wiesel LL, Barritt AS, Stumpe WM. The synergistic action of para-aminobenzoic acid and cortisone in the treatment of rheumatoid arthritis. Am J Med Sci 1951;243-8. DOI
- Taylor, S. E. and Dorris, R. L. Modification of local anesthetic toxicity by vasoconstrictors. Anesth.Prog 1989;36(3):79-87.
- Davies, D. M. and Cavanagh, J. Jaundice from potassium p-aminobenzoate. Lancet 4-22-1967;1(7495):896. PubMed
Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.
Taking Para-aminobenzoic Acid (paba) and Evinacumab-Dgnb Together: Common Questions
Is it safe to take Para-aminobenzoic Acid (paba) with Evinacumab-Dgnb?
Does Para-aminobenzoic Acid (paba) interact with any other medications?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Keep Exploring
Still Have a Question About Evinacumab-Dgnb and Para-aminobenzoic Acid (paba)?
Our pharmacists answer your medication & supplement questions — free.
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.